Top compounds associated with response to ADGRE1


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib FIMM pan-cancer AAC -0.33 0.04
mRNA Vandetanib CCLE pan-cancer AAC -0.097 0.04
mRNA Bleomycin GDSC1000 pan-cancer AAC 0.073 0.04
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.04
mRNA staurosporine CTRPv2 pan-cancer AAC -0.15 0.04
mRNA STF-62247 GDSC1000 pan-cancer AAC -0.066 0.04
mRNA TPCA-1 CTRPv2 pan-cancer AAC 0.065 0.04
mRNA AZD6244 CCLE pan-cancer AAC -0.088 0.04
mRNA Imatinib GDSC1000 pan-cancer AAC -0.1 0.04
Download CSV